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Mitogen-activated protein kinase (MAPK) signaling pathways are key mediators of eukaryotic transcriptional responses to extracellular
signals. These pathways control gene expression in a number of ways including the phosphorylation and regulation of transcription factors, co-
regulatory proteins and chromatin proteins. MAPK pathways therefore target multiple components of transcriptional complexes at gene promoters
and can regulate DNA binding, protein stability, cellular localization, transactivation or repression, and nucleosome structure. Recent work has
uncovered further complexities in the mechanisms by which MAPKs control gene expression including their roles as integral components of
transcription factor complexes and their interplay with other post-translational modification pathways. In this review I discuss these advances with
particular focus on how MAPK signals are integrated by transcription factor complexes to provide specific transcriptional responses and how this
relates to cellular function.
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The exposure of cells to extracellular signals elicits
changes in gene expression that promote appropriate physi-
ological responses. These signals activate multiple intracellu-
lar signaling pathways that are integrated at gene promoters
and target transcription factors, co-regulators and chromatin
proteins. The phosphorylation and de-phosphorylation of
transcriptional regulators mediated by specific protein kinases
and protein phosphatases is the most common mechanism of
controlling gene expression [1,2]. The MAPK group of
signaling pathways are important mediators of transcriptional
responses to extracellular signals that include growth factors,
hormones, cytokines and environmental stresses [3–10].
These pathways are evolutionarily conserved amongst eukar-
yotes and in recent years a large number of proteins involved
in gene transcription have been identified as their targets [8].
MAPK pathways can alter the activities of transcriptional
regulators in many ways including controlling their localiza-⁎ Tel.: +44 161 275 7825; fax: +44 161 275 5082.
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to other components of transcriptional complexes and to
DNA, and their ability to remodel chromatin structure. Many
of these mechanisms have been discussed extensively in
previous reviews [1,8–10]. In this review I focus on recent
advances including (i) how transcription factors can interpret
the kinetics of MAPK activity and therefore respond
appropriately, (ii) how components of MAPK pathways, in
addition to their enzymatic role, are integral parts of
transcriptional complexes, and (iii) how MAPK pathways
and other post-translational modification pathways are inte-
grated to control gene expression.
2. MAPK signaling pathways
MAPK signaling pathways are evolutionarily conserved in
eukaryotes and are involved in many cellular processes
including growth, differentiation, apoptosis and the immune
response [3–7]. These pathways feature a conserved signaling
cascade downstream of small GTPases of the Ras and Rho
families. The cascade consists of a MAPK kinase kinase
(MKKK) which phosphorylates and activates a MAPK kinase
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Thr and Tyr residues within a conserved motif located in the
activation loop of the kinase [3–7].
In the budding yeast Saccharomyces cerevisiae there are five
MAPK pathways which control diverse cellular processes
including mating, sporulation, cell wall integrity, invasive
growth and pseudohyphal growth, and the response to high
osmolarity [3]. For example, in response to high osmolarity, the
high osmolarity glycerol-1 (Hog1) pathway is activated leading
to increased expression of enzymes required for the synthesis of
the osmotic stabilizer glycerol, while genes required for mating
are controlled by a pathway that signals via the Fus3 and Kss1
MAPKs [3].
In mammalian cells there are four major MAPK pathways
leading to the activation of extracellular signal-regulated kinase
(ERK), c-Jun N-terminal kinase (JNK), p38, and extracellular
signal-regulated kinase 5 (ERK5; also called Big MAP kinase-1
(BMK1)) [4–7]. There is increased complexity within the
mammalian pathways due to the occurrence of multiple gene
products (i.e. ERK1 and ERK2; JNK1, JNK2, and JNK3; p38α,
p38β, p38γ, and p38δ) [4–6]. In addition, further isoforms are
generated by differential splicing. For example the three Jnk
genes encode a total of ten distinct isoforms [11]. The ERK
pathway is mainly activated by growth factors and hormones
while the JNK and p38 pathways are activated by environmen-
tal stress and pro-inflammatory cytokines [4–6]. The ERK5
pathway is activated by specific mitogens and stresses [7]. In
addition to the four major mammalian MAPK pathways there
are a number of other protein kinases that share significant
sequence homology to MAPKs [12,13]. Although relatively
poorly characterized, a number of these, including ERK7,
ERK8 and Nemo-like kinase (NLK), have also been shown to
regulate transcriptional events [12,13]. The components of
MAPK pathways associate with many types of regulatory
proteins including protein phosphatases, which de-phosphory-
late and inactivate the protein kinase components of the
pathway [14], and scaffold proteins which co-localize compo-
nents of the pathways, regulate their activities, and direct the
pathways to specific targets [15,16].
The minimal consensus phosphorylation motif in MAPK
substrates is [Ser/Thr]-Pro [8–10]. Activated MAPKs can
directly phosphorylate their substrates in the cytoplasm or
nucleus to regulate transcription [8–10]. MAPKs also
phosphorylate and activate downstream protein kinases that
can target proteins involved in transcription [17]. For
example, mammalian MAPKs activate members of the
Ribosomal S6 kinase (RSK), MAPK-interacting kinase
(MNK), MAPK-activated protein kinase (MAPKAPK), and
the mitogen- and stress-activated protein kinase (MSK)
families [17].
The organization and regulation of mammalian MAPK
pathways is highly conserved between yeast and mammals [3–
7]. Indeed, complementation experiments have demonstrated
that some mammalian MAPKs can functionally replace their
homologs in yeast [18]. It is likely therefore that the
mechanisms governing MAPK regulation of transcription are
similar across eukaryotes.3. Interaction of MAPKs with transcription factor
complexes
MAPKs can bind to many types of proteins including
substrates, other protein kinases, protein phosphatases,
scaffold or adaptor proteins, cytoskeletal proteins, as well as
transcriptional proteins [19,20]. In order to efficiently
phosphorylate their substrates, including transcription factors,
MAPKs often directly interact with them via conserved
docking sites [19,20]. In some instances such docking sites on
transcription factors can act as sensors that detect the strength
and duration of MAPK activity in cells [21], while other
recent work suggests that MAPKs could, in addition to their
enzymatic role, play important adaptor roles themselves and
directly recruit proteins into transcription factor complexes on
gene promoters [22].
3.1. Docking of MAPKs to their substrates
In addition to the [Ser/Thr]-Pro phosphoacceptor motif,
MAPK substrates contain docking sites for binding to the
MAPK [8,19,20]. These docking sites are essential for efficient
phosphorylation to occur and also impart specificity as they
selectively bind to MAPK sub-types [8,19,20]. Several types of
docking sites have been uncovered, the best characterized of
which are the D (or δ)-domains which feature a cluster of basic
residues upstream of a Leu-x-Leu motif and/or a hydrophobic
triplet [8,19,20]. D-domains can be found upstream or
downstream of the phosphoacceptor sites and the exact
composition and spacing of the residues determines the
specificity for particular MAPKs [8,19,20]. In addition, X-ray
crystallography experiments featuring D-domain peptides
bound to MAPKs indicate that D-domains induce distinct
conformation changes in different MAPKs that may also
contribute to the specificity of phosphorylation [23–25]. D-
domains have been demonstrated to play an extensive role in
MAPK signaling in both yeast and mammals, as they are also
present in other MAPK binding proteins including scaffold
proteins, MKKs, and protein phosphatases [19,20]. A second
type of docking site commonly found in transcription factors is
the DEF domain (docking site for ERK, FXFP; also known as
the FxFP motif) that can be recognised by ERK and the p38α
isoform and is usually found downstream of the phosphoac-
ceptor sites [8,19,20,26,27]. This motif contains a consensus
sequence of [Phe/Tyr]-x-[Phe/Tyr]-Pro. MAPKs can also bind
to other sites in substrates that do not resemble D-domains or
DEF domains, suggesting that there may be variety of MAPK
docking interactions with their substrates [28,29].
It is important to note that some substrates contain more than
one type of docking site and can recruit combinations ofMAPKs
depending on the stimuli. For example, JunD contains both a D-
domain and a DEF domain [30]. The D-domain is required for
binding to JNK and for JNK-mediated phosphorylation of JunD
in response to stress, while both the D-domain and the DEF
domain contribute to ERK phosphorylation of JunD in response
to growth factors [30]. Further complexity arises from the
observation that the related AP-1 family member c-Jun (which
1287A.J. Whitmarsh / Biochimica et Biophysica Acta 1773 (2007) 1285–1298contains a D-domain but not a DEF domain) binds to JNK via its
D-domain and can heterodimerize with JunD [31]. This allows
the c-Jun-bound JNK to phosphorylate JunD in trans [31]. As
JunD is less efficiently activated by JNK compared to c-Jun
[30,31], it is possible that at promoters containing c-Jun/JunD
heterodimers the c-Jun-bound JNK contributes to a more robust
activation of JunD transcriptional activity. Like JunD, the ETS-
domain factor Elk-1 recruits ERK to both D and DEF domains
and it has been reported that each domain can target ERK to
phosphorylate specific residues within the Elk-1 transcriptional
activation domain (TAD), thereby collaborating in Elk-1
activation [32]. In contrast, distinct MAPK docking sites may
direct phosphorylation events that have opposing effects on
transcription factor function, as exemplified by a related ETS-
domain factor Net/SAP-2, which binds to ERK and JNK via two
separate D-domains [33]. These examples suggest that tran-
scription factors utilize different combinations of MAPK
docking sites to direct phosphorylation events that regulate
their activities in response to distinct stimuli.
Due to their central roles in many pathological conditions
there have been tremendous efforts to generate specific
pharmacological inhibitors of MAPK pathways [34]. In the
future, exploiting the specificity of docking domains for
MAPKs may prove a viable alternative to the generation of
ATP-competitive inhibitors that inhibit protein kinase activity
[35]. The ATP binding region displays a high level of
conservation amongst the MAPK family groups and also with
other protein kinases which has made the generation of highly
specific inhibitors of MAPK activity problematic [34,35].
Recent work utilizing peptides derived from D-domains found
that these could be potent inhibitors of MAPK signaling in vivo,
while small molecule inhibitors of ERK binding to D-domains
have been demonstrated to block ERK phosphorylation of
substrates and to reduce the proliferation of cancer cell lines
[29,35,36]. This raises the possibility that specific MAPK
functions could be blocked in vivo through the targeting of
distinct MAPK interactions. It is known that D-domains and
DEF domains bind to distinct regions in ERK2 and that
mutations in ERK2 that abrogate DEF domain binding do not
block binding to D-domains or affect the ERK2 phosphotrans-
ferase activity [37,38]. In addition, peptides that are based on
the D-domain can block ERK2 phosphorylation of Elk-1 but do
not affect ERK2 phosphorylation of microphthalmia-associated
transcription factor (MITF) which contains a different docking
site [29]. Indeed, blocking MAPK docking sites may be an
important mechanism for downregulating transcription factor
function in cells. For example, the Drosophila transcriptional
activator Pointed-P2 is activated following phosphorylation by
dERK (Rolled) but this can be inhibited by the binding of Mae
to the dERK docking site on Pointed-P2, which prevents dERK
binding [39].
3.2. Docking sites on transcription factors can act as MAPK
signal sensors
It has been known for some time that the duration and
strength of MAPK signaling can regulate distinct cell fatedecisions. For example, in PC12 pheochromocytoma cells the
sustained activation of ERK leads to differentiation while
transient ERK activation promotes proliferation [40]. Correla-
tions between the duration of ERK signaling and cell behaviour
have also been uncovered in other cell types. In fibroblasts
sustained ERK activity is required for cell cycle re-entry and
proliferation [21,40,41]. This occurs via the expression of
proteins required for cell cycle re-entry such as cyclin D1 [21]
and by the repression of anti-proliferative genes [41]. Recent
studies have addressed the molecular mechanisms by which
transcription factors interpret differences in ERK signaling
kinetics and docking interactions appear to play a key role.
The immediate early gene (IEG) product c-Fos is a
component of AP-1 transcription factor complexes and is
expressed in response to growth factors that cause both transient
and sustained ERK signaling [9,21,42]. However, the protein is
unstable unless it is phosphorylated at the C-terminus. Under
conditions where ERK activity is transient, the c-Fos protein is
not phosphorylated and is degraded, while sustained ERK
activity leads to C-terminal phosphorylation of c-Fos and its
stabilization and activation [21,43] (Fig. 1A). The DEF domain
of c-Fos plays a critical role in this process. c-Fos is initially
phosphorylated at two C-terminal sites (Ser362 and Ser374) by
ERK and the ERK-regulated protein kinase RSK [43] (Fig. 1A).
In addition to stabilizing the c-Fos protein, these phosphoryla-
tions act as a priming event that permits the access of ERK to
the DEF domain in c-Fos and leads to the phosphorylation of
further sites (Thr325 and Thr331) which contribute to c-Fos
transcriptional activity [43] (Fig. 1A). The importance of the
DEF domain has been confirmed as the mutation of key
residues disrupts c-Fos-mediated signaling [43].
In addition to c-Fos, a number of other DEF domain-
containing IEG products can act as sensors of ERK activity
including Fra-1, Fra-2, and c-Myc [44]. These IEG products
appear to be highly sensitive as they can detect relatively small
changes in ERK signal strength [44], however, they may also
act as gatekeepers by only allowing efficient DEF domain-
dependent phosphorylation of transcription factors when ERK
activity reaches a threshold strength or duration. In addition, it is
proposed that these transcription factors may contribute to
sustaining nuclear ERK activation by retaining the active ERK
in the nucleus via DEF domain binding and by preventing the
interaction of ERK with MAPK phosphatases [21].
It is likely that transcription factors can sense the activity
levels of other MAPKs in addition to ERK. For example,
DEF domains have been demonstrated to bind to p38α in
addition to ERK [27], while the duration of JNK activation by
tumor necrosis factor (TNF) determines distinct cell fates
[45].
A variation on this theme is the ability of docking sites in
transcription factors to recognise the activation state of MAPKs.
For example, experiments in fibroblasts have demonstrated that
distinct JNK isoforms differentially regulate gene expression
[46] and proliferation [47,48]. Fibroblasts that lack JNK1
activity have a small defect in proliferation while those deficient
in JNK2 activity show enhanced proliferation [47,48]. This
correlates with reduced levels of c-Jun and AP-1 activity in the
Fig. 1. MAPK regulation of c-Fos transcriptional activity and cell proliferation. (A) IEG gene products such as the AP-1 family member c-Fos can interpret the strength
and duration of ERKMAPK activation in cells and direct distinct proliferative outcomes [21,43]. Stimuli that cause transient activation of ERK induce the expression
of c-Fos but the protein is rapidly degraded by the proteosome. However, in response to sustained ERK activity, the expressed c-Fos protein is stabilized by the
phosphorylation (P) of two sites within the C-terminus (Ser362 and Ser374) by ERK and RSK. This acts as a priming event that permits the DEF domain on c-Fos to
bind to ERK which results in further phosphorylation of c-Fos (at Thr325 and Thr331) and subsequent transcriptional activation and cell proliferation [21,43]. (B)
ERK5 regulates c-Fos stability and nuclear localization. ERK5 phosphorylates c-Fos at Ser32 and Thr232 (sites distinct from the ERK1/2 sites) and blocks c-Fos
nuclear export as well as its binding to the E3 ubiquitin ligase UBR1, which can mediate c-Fos degradation [88,89]. Sustained ERK5 activity promotes c-Fos nuclear
localization and stability resulting in enhanced cell growth.
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deficient cells [48]. A model has been proposed whereby in
unstimulated cells JNK2 preferentially associates with c-Jun via
its D-domain resulting in the degradation of c-Jun by the
ubiquitin-proteosome pathway [48,49], while in stimulated cells
the specificity of c-Jun for JNK isoforms alters and it
preferentially binds to activated JNK1 and is phosphorylated
leading to its transcriptional activation [48]. However, it is also
reported that the loss of JNK2 protein leads to enhanced JNK1
function indicating that the phenotype observed in JNK2-null
fibroblasts may be a result of increased JNK1 activity, possibly
due to reduced competition for upstream activators [50]. Indeed,
using a chemical genetics approach to specifically inhibit JNK2
activity, rather than engineering the complete loss of JNK2
protein, it was demonstrated that both JNK1 and JNK2
positively contribute to c-Jun activity [50]. Binding studies of
JNK isoforms to c-Jun [48,51], along with a study of ERK
docking motifs in ETS2 [52], do, however, suggest that docking
domains in transcription factors are capable of distinguishing
between the activation states of highly similar MAPK isoforms,
thereby contributing to signaling specificity.3.3. MAPKs as components of transcription factor complexes
The well-documented interactions between MAPKs and
transcription factors suggests that they may be part of
transcriptional complexes at gene promoters. Indeed, studies
have demonstrated that MAPKs can be retained in the nucleus
by virtue of their interactions with transcription factors but until
recently there was limited evidence supporting their recruitment
to promoters. Now a number of studies, in particular those
focussed on the high osmolarity sensing Hog1 pathway in S.
cerevisiae, have provided strong evidence that MAPKs can be
recruited to genes and are integral components of transcription
factor complexes [22,53–55].
The Hog1 pathway coordinates an initial osmotic stress relief
response of cells with the transcriptional up-regulation of genes
required for adaptation to high osmolarity [56,57]. Hyperosmo-
tic stress in the form of high salt concentration causes the rapid
activation of Hog1 and also the dissociation of transcriptional
regulators from chromatin [56,57]. Initially, Hog1 protects the
ability of the cell to mount an appropriate transcriptional
response by phosphorylating the Na+–H+ antiporter Nha1 and
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association of transcriptional regulators with chromatin [57].
Active Hog1 can then regulate a number of transcription factors
(e.g. Sko1, Hot1, Msn2, Msn4) that target particular osmotic
stress-responsive genes [53,56]. Using chromatin immunopre-
cipitation (ChIP) analysis, Hog1 was shown to be a component
of several distinct promoter bound complexes [53–55,58] (Fig.
2). At the GPD1 gene promoter constitutively bound Hot1
recruits Hog1 in response to osmotic stress, while at the STL1
promoter the binding of both Hot1 and Hog1 was demonstrated
to be interdependent [53] (Fig. 2A, B). At other promoters of
osmotic stress responsive genes, such as the CTT1 and HSP12
promoters, the zinc finger-containing transcription factors Msn2
and Msn4 recruit Hog1 following osmotic stress and the
presence of Hog1 is required for the recruitment of Hot1 [53].
Surprisingly, Hot1 or Msn2–Msn4 phosphorylation by Hog1 is
not essential for the regulation of Hot1-dependent and Msn2–
Msn4-dependent promoters, respectively. Instead, activated
Hog1 appears to mediate the recruitment of the general
transcription machinery (GTM) to the promoter in response to
osmotic stress through association with RNA polymerase II,Fig. 2. The yeast Hog1 MAPK is an integral component of transcription factor compl
number of osmoresponsive genes through distinct mechanisms [53,54]. At the GPD
Hog1 in response to osmotic stress while at the STL1 promoter (B) osmotic stress in
phosphorylate Hot1 this does not appear to be required for transcription to occur. A
bound by the Sko1–Cyc8–Tup1 co-repressor complex. High osmolarity causes Sko
Cyc8–Tup1 repressor complex to a transcriptional activator via the recruitment of the
it is proposed that active Hog1 promotes transcription by recruiting components of the
as the Rpd3–Sin3 HDAC complex [58,123]. It is not clear whether Hog1 phosphorsubunits of mediator, and general transcription factors (GTFs)
[58]. It is currently unclear whether Hog1 phosphorylates
components of the GTM in addition to recruiting them.
Further evidence supporting the importance of Hog1 at
osmotic stress-responsive promoters has come from studies of
the Sko1 repressor which binds to subset of these promoters. In
the absence of osmotic stress, Sko1 recruits the Cyc8-Tup1 co-
repressor complex to repress gene transcription [54,59] (Fig.
2C). In conditions of high osmolarity, Sko1 recruits active Hog1
and is phosphorylated by Hog1 which converts the Sko1–
Cyc8–Tup1 repressor complex into an activator by permitting
the recruitment of the SAGA and SWI–SNF chromatin
remodelling complexes [54] (Fig. 2C). Similar to Hot1- and
Msn2/Msn4-dependent promoters, the active Hog1 also func-
tions to recruit components of the GTM [54].
It is unclear whether the recruitment of Hog1 to gene
promoters is required for the transcription of all Hog1-
dependent genes, or just a subset of these genes. A recent
genome-wide analysis involving ChIP experiments and DNA
microarrays suggests the latter as Hog1 was only detected at a
minority of Hog1-dependent genes [55]. This approach alsoexes. In response to osmotic stress Hog1 is recruited to the promoter regions of a
1 promoter (A) constitutively bound Hot1 transcription factor recruits activated
duces the interdependent binding of Hot1 and activated Hog1. While Hog1 can
third mechanism occurs at the GRE2 promoter (C) which in unstressed cells is
1 to recruit activated Hog1 which phosphorylates Sko1 and converts the Sko1–
SAGA and SWI–SNF chromatin remodelling complexes. At all these promoters
GTM including RNA polymerase II (Pol II), GTFs, subunits of mediator, as well
ylation of components of the GTM also contributes to gene transcription.
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response to mating pheromone, the MAPKs Fus3 and Kss1
were detected at a subset of mating-specific genes [55].
Hog1, in addition to its role in the initiation of transcription,
is also critical for transcriptional elongation of osmotic stress-
responsive genes [60]. Active Hog1 is recruited to the coding
region of these genes and enhances the association of elongating
RNA polymerase II and elongation factors [55,60]. The binding
of Hog1 to the transcribed regions appears to be dependent on
the 3′ UTR and is independent of its role in transcriptional
initiation complexes [60]. It is possible that Fus3 and Kss1 may
also play a role in elongation. Indeed, both kinases show greater
occupancy of the transcribed regions of the genes they associate
with than the promoter regions [55]. Taken together these
studies indicate a critical role for Hog1 in the initiation of
transcription and in transcriptional elongation and suggest that
other S. cerevisiae MAPKs may have similar functions.
Considering the conservation of MAPK pathways through
evolution, it is highly likely that mammalian MAPKs are also
components of transcriptional complexes. Indeed ERK5 may
have a direct role in transcriptional activation as located within
its extended C-terminus is a strong transcriptional activation
domain, although the functional role of this is not understood
[61]. Direct evidence of mammalian MAPK recruitment to
specific gene promoters in vivo has been scarce, however it has
recently been demonstrated using ChIP experiments that ERK1
and ERK2 are recruited to AP-1 reporter genes in a phorbol
ester-dependent manner [62], while inactive JNK is recruited to
the c-jun promoter in response to glucocorticoid [63], and
p38α/β is recruited to regulatory elements located in the
promoters of the muscle-specific genes Myog and Ckm [64]. In
the latter example, the inhibition of p38 activity prevented the
recruitment of the SWI–SNF chromatin remodelling complex
and abrogated gene expression [64]. These data suggest that p38
can associate with promoter-bound complexes and selectively
target SWI–SNF to distinct regulatory elements to promote the
expression of muscle-specific genes. The precise mechanism by
which p38 regulates these genes is unclear, however, it may
involve the direct phosphorylation of the SWI–SNF complex as
the BAF60 subunit can be phosphorylated by p38 in vitro [64].
A number of studies in mammalian cells have linked MAPK
signaling to components of the GTM. p38 can bind to RNA
polymerase II [58], while ERK can phosphorylate its C-terminal
tail (CTD) [65]. Both p38 and ERK can phosphorylate the TATA-
binding protein (TBP) component of the TFIID transcription
factor complex and potentially enhance its binding to the TATA
box [66,67]. p38 also enhances STAT1-dependent gene expres-
sion in response to interferon (IFN)-γ independently of its ability
to phosphorylate STAT1, suggesting that p38 might be present at
STAT1-regulated gene promoters and could potentially recruit
and/or phosphorylate GTM components [68]. In addition to
regulating RNA polymerase II-dependent transcription, ERK can
regulate GTFs associated with RNA polymerases I and III
including TIF-IA and TFIIIB, respectively [69,70]. Taken
together these observations suggest that MAPKs may be integral
components of transcriptional complexes and can regulate
multiple aspects of transcriptional control at gene promoters.3.4. MAPK scaffold proteins as part of transcriptional
complexes
There is increasing evidence that MAPK pathways are
regulated by scaffold proteins [15,16]. These are a diverse group
of proteins that may localize MAPK components to particular
cellular compartments and control their activities [15,16]. Some
scaffold proteins may directly link MAPK pathways to specific
substrates, including transcription factors. For example, in
Drosophila a multi-domain protein connector of kinase to AP-1
(CKA) functions in the JNK pathway and is important for the
expression of decapentaplegic (DPP) in leading edge epithelial
cells [71]. CKA promotes dJNKK (Hep) activation of dJNK
(Bsk) and may also link the activated JNK to its substrates by
binding to the AP-1 proteins (dFos and dJun) which control
DPP gene transcription [71].
The mammalian scaffold proteins JNK-interacting protein-1
(JIP1) and JNK-associated leucine-zipper protein (JLP) have
also been reported to form complexes between JNK and p38
and some of their transcriptional targets [72,73]. In addition,
JIP1 has been observed localized in the nucleus with the
transcriptionally active amyloid precursor protein (APP)-
intracellular domain (AICD) and the histone acetyltransferase
(HAT) TIP60 [74]. The functional role of JIP1 in this complex is
not known although in reporter gene assays JIP1 enhances
AICD transcriptional activity [75] and displays intrinsic
transcriptional activity [75,76].
It is possible that, like MAPKs, scaffold proteins may be
recruited to genes. The S. cerevisiae scaffold protein Ste5, that
coordinates and binds to the components of the mating pathway
[3,16], is found occupying the same mating genes as those
bound by the MAPKs Fus3 and Kss1 [55]. This suggests that
scaffold proteins can coordinate the activation of MAPK
pathways in the cytoplasm (or at the plasma membrane) and
also regulate the action of MAPKs at their target genes within
the nucleus. It will be interesting to see whether other scaffold
proteins are also part of transcription factor complexes. It is
reported that JIP1 can bind to the GTII regulatory element at the
GLUT2 promoter and regulate its expression [76,77] but the
binding has not been confirmed in vivo.
4. Regulation of transcription by the interplay of MAPK
pathways with other post-translational modification
pathways
Transcription factors and chromatin proteins are subject to
multiple post-translational modifications (PTMs) in addition to
phosphorylation. These include acetylation, methylation,
ubiquitination, and sumoylation amongst others. It is clear
that these modifications are not occurring in isolation but can
be interdependent, being either collaborative or antagonistic.
In addition, the signalling pathways leading to these PTMs
can cross-talk to provide a further level of regulation. Here I
will focus on recent work uncovering the interplay between
MAPK pathways and pathways leading to the ubiquitination,
sumoylation and acetylation of transcriptional regulatory
proteins.
Fig. 3. The selective degradation of the Tec1 transcription factor promotes
signaling specificity during yeast mating response. (A) The S. cerevisiaeMAPK
pathways that are required for mating and filamentous growth share a number of
conserved components but can activate distinct transcriptional programs [3,82].
Mating genes are regulated by the transcription factor Ste12, while genes
required for filamentous growth are regulated by the cooperative binding of
Ste12 and Tec1 to promoters. (B) In response to pheromone both Fus3 and Kss1
MAPKs are activated leading to the activation of Ste12 by phosphorylation (P)
and the transcription of mating-specific genes [82]. The activated Fus3 limits the
extent and duration of Kss1 activation and also phosphorylates Tec1 at Thr273
leading to its degradation by the proteosome [83–87]. These regulatory
mechanisms result in a lack of activation of genes required for filamentous
growth.
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MAPKs
MAPKs can control the protein levels of transcription factors
in cells by regulating their stability via the ubiquitin-proteosome
system. Proteolysis allows for the rapid and irreversible loss of
proteins and thereby enables rapid changes in cell function [78].
Ubiquitin is attached to target proteins at Lys residues by an
enzyme complex consisting of E1, E2 and E3 subunits and the
ubiquitinated proteins are degraded by the proteosome [78].
There are many examples of MAPKs promoting ubiquitin-
dependent transcription factor degradation via phosphorylation
of the factor [8]. In some cases, the transactivation of a
transcription factor in response to MAPK phosphorylation is
directly linked to their degradation, thereby providing a
mechanism for short-lived activation. For example, the nuclear
hormone receptors progesterone receptor (PR) and retinoic acid
receptor-γ2 (RARγ2) are activated and subsequently degraded
in response to ligand-dependent activation of the ERK and p38
signaling pathways, respectively [79,80]. Such a response may
involve cooperation with other PTMs as occurs during the
regulation of the haematopoietic transcription factor GATA-1.
The acetylation of GATA-1 is required for its binding to DNA
and its transcriptional activity [81]. Active acetylated GATA-1
is degraded following ERK phosphorylation of a number of
sites in the protein [81]. Thus, only GATA-1 that is both
acetylated and phosphorylated is degraded, providing a
mechanism of selectively targeting the transcriptionally active
GATA-1 [81].
Recent work in S. cerevisiae has demonstrated that the
selective degradation of transcription factors can promote
signaling specificity. The yeast MAPK pathways that are
required for mating and filamentous growth share several
common components, including the MKKK Ste11 and the
MKK Ste7, but each pathway activates a distinct transcrip-
tional program [3,82] (Fig. 3A). Genes involved in mating are
regulated by the Ste12 transcription factor which binds to sites
in the promoters of mating genes while genes required for
filamentous growth are activated by a hetero-multimer of Ste12
and a second transcription factor, Tec1 [82]. In response to
mating pheromone the MAPKs Fus3 and Kss1 are activated by
the Ste11–Ste7 pathway in a complex with the scaffold protein
Ste5, while during filamentous growth only Kss1 is activated
by the Ste11–Ste7 pathway [82] (Fig. 3A). However, the Kss1
activated by pheromone does not up-regulate filamentous
growth-specific genes except if Fus3 activity is lost, indicating
that Fus3 restricts Kss1-mediated activation of these genes
[82,83]. One way this occurs is by the activated Fus3 limiting
the magnitude and duration of Kss1 activation, although the
precise mechanism is unclear [84] (Fig. 3B). An additional
mechanism involves Fus3 phosphorylating the filamentous
growth-specific transcription factor Tec1 at Thr273 which
leads to its ubiquitination via an SCF ubiquitin ligase complex
and its degradation, thereby preventing the transcription of
filamentation-specific genes [85–87] (Fig. 3B). Interestingly,
the extent of Tec1 degradation is proportional to the
concentration of pheromone. Therefore, at low pheromoneconcentrations Tec1 levels may remain high enough to allow
the yeast to forage for optimal mating conditions while still
being primed for mating. These studies demonstrate that the
signal-induced degradation of transcription factors in compet-
ing pathways may provide an important mechanism for
ensuring signaling specificity. This regulation at the level of
MAPK targets allows the control of specific transcriptional
outputs while providing the flexibility to permit other MAPK
outputs that support the desired physiological response. In
addition, as proteolysis is rapid and MAPK pathways often
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transcriptional programs.
MAPKs are also reported to promote the stability of
transcription factors. As discussed in Section 3.2, the
phosphorylation of c-Fos following sustained ERK1/2 activity
leads to its stabilization [21,43]. However, it was recently
reported that ERK5 could also regulate c-Fos stability. ERK5
phosphorylates c-Fos at sites distinct from the ERK1/2 sites and
blocks c-Fos nuclear export as well as its binding to the E3
ubiquitin ligase UBR1, which can mediate c-Fos degradation
[88,89] (Fig. 1B). Therefore, sustained ERK5 activity promotes
c-Fos nuclear localization and stability resulting in enhanced
cell growth.
It is clear that there are multiple levels of regulation of
transcription factors by ubiquitination and proteolysis. For
example, as mentioned previously (in Section 3.2), inactive
JNK isoforms may target transcription factors including JunB,
ATF-2 and p53 for degradation, although the mechanisms
involved are unclear [49,90]. The role of JNK phosphorylation
of c-Jun in regulating its stability is more controversial. Several
studies have demonstrated that JNK phosphorylation of c-Jun
stabilizes the protein and thereby contributes to its transcrip-
tional activity [49,91], however there is also evidence that JNK
phosphorylation of c-Jun can contribute to its degradation [92].
At least three distinct ubiquitin ligase complexes (Fbw7,
COP1, and Itch) have been implicated as mediators of c-Jun
ubiquitination and degradation [92–94]. One of these, the SCF-
type ubiquitin ligase Fbw7, is reported to preferentially
associate with c-Jun that has been phosphorylated by JNK
and to target it for degradation [92]. The depletion of Fbw7
from neurons by siRNA resulted in increased levels of
phosphorylated c-Jun, increased AP-1 activity, and increased
apoptosis [92]. However, a second study found no evidence for
Fbw7 recruitment to c-Jun phosphorylated at the major JNK
sites (Ser63 and Ser73) but instead demonstrated that Fbw7
recruitment required the phosphorylation of the c-Jun C-
terminus by glycogen synthase kinase-3 (GSK3) [95]. A
possible explanation for this discrepancy is that in neurons the
basal level of JNK1 activity is high and this appears to be
important for regulating microtubule dynamics and neuron
morphology [96,97]. However, the JNK-c-Jun pathway is a
major apoptotic pathway in neurons [6,98] and Fbw7 may
therefore function to dampen down the c-Jun branch of the
JNK pathway that leads to apoptosis and thereby allow the
neurons to tolerate potentially neurotoxic levels of JNK activity
[92].
A further twist to the regulation of c-Jun is that the activity
of one of the ubiquitin ligases that targets it is itself regulated
by JNK phosphorylation. Itch is a HECT-domain ubiquitin
ligase that targets both c-Jun and the related JunB for
degradation [94]. In mice lacking either Itch or JNK1, both
c-Jun and JunB accumulate in T cells and there is excessive
production of Th2 cytokines such as IL-4 [99,100]. T cell
activation leads to the rapid phosphorylation of Itch by JNK
which increases the catalytic activity of Itch and results in
increased ubiquitination and degradation of the Jun transcrip-
tion factors, thereby modulating cytokine production [94]. JNKphosphorylates three sites within the Pro-rich region of Itch
and disrupts an inhibitory intramolecular interaction between
the WW domain and the catalytic HECT domain leading to a
conformational change that enhances Itch E3 ligase activity
[101]. It will be interesting to see if JNK phosphorylation of
Itch regulates other Itch transcriptional targets such as
SMAD2, p63, and p73 [102–104].
These recent studies on the regulation of the stability of Jun
family members by the ubiquitin-proteosome system demon-
strate a high degree of complexity. Several different ubiquitin
ligase complexes are involved and their actions can be
differentially regulated by JNK signaling. It seems likely that
the protein stability of other transcriptional targets of MAPKs is
regulated in a similarly complex way.
4.2. Regulation of transcription factor sumoylation by MAPKs
In recent years many transcriptional regulators have been
demonstrated to be sumoylated. This involves the covalent
conjugation of small ubiquitin-related modifier (SUMO) to
target proteins. Analogous to ubiquitination, sumoylation
occurs via a SUMO ligase complex of E1, E2 and E3 subunits
[105,106]. The E1 enzyme activates SUMO which is then
transferred to the target lysine residue in the substrate by the E2
conjugating enzyme Ubc9, often aided by E3 ligases including
protein inhibitor of activated STAT (PIAS) proteins, RanBP2
and Pc2 [105,106]. In many substrates Ubc9 recognises the
target Lys residue within a consensus sequence ψKxE (where ψ
is a bulky hydrophobic residue) although additional specificity
determinants have also been proposed [105–108]. Similar to
phosphorylation, SUMO modification is reversible and con-
jugates can be targeted by SUMO isopeptidases [105,106]. The
sumoylation of proteins can regulate many aspects of their
function including cellular location, stability, and in the case of
transcription factors, their transactivation or repressive proper-
ties [105,106].
There is evidence that the MAPK pathways can cooperate
with or be antagonistic with the SUMO pathway in order to
regulate transcription factor function. A prime example of this
occurs as part of the regulatory crosstalk between the previously
discussed mating and filamentous growth pathways in S.
cerevisiae, where the sumoylation of the Ste12 and Tec1
transcription factors provides an additional level of regulation.
In response to mating pheromone Ste12 is sumoylated
dependent on Fus3 activity and this promotes Ste12 protein
stability and transcriptional activity at mating genes [109].
Conversely, the filamentation pathway-specific factor Tec1
undergoes a loss of sumoylation [109] leading to its rapid
degradation via the ubiquitin-proteosome pathway (as described
in Section 4.1), thus contributing to a switch from the
filamentous growth transcriptional program to the mating
transcriptional program.
In mammalian cells sumoylation is also regulated by
MAPKs. The mammalian SUMO isoform SUMO-1 is conju-
gated to Lys229 and Lys257 on c-Jun [110,111] but the level of
sumoylation is decreased upon c-Jun phosphorylation by JNK
[110]. Experiments demonstrating that the mutation of the JNK
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while sumoylation-deficient mutants of c-Jun have increased
transcriptional activity, indicate that sumoylation negatively
regulates c-Jun activity [110,111]. A more detailed analysis of
the mechanisms involved in the interplay between the SUMO
andMAPK pathways has come from studies of the ETS-domain
transcription factor Elk-1, which is implicated in the expression
of a number of IEGs including c-Fos, Egr1 and Mcl-1 [112]. In
the absence of growth promoting signals, Elk-1 activity is
repressed due to SUMO conjugation to Lys residues located
within a C-terminal transcriptional repression domain [113]
(Fig. 4). In response to growth factor stimulation, Elk-1 is
phosphorylated by ERK within its C-terminal TAD [112–114].
This leads to the activation of Elk-1 target genes by promoting
the loss of SUMO conjugation and de-repression [113]. It also
allows the recruitment of the Mediator complex [115] and
possibly other co-activators that link Elk-1 to the GTM. One of
the mechanisms by which the sumoylation of Elk-1 causes
transcriptional repression is by the recruitment of a histone
deacetylase-2 (HDAC2) co-repressor complex [116] (Fig. 4).
This complex may remove acetyl groups from local histones
and thereby promote the formation of a repressive chromatin
structure. In addition to this direct role in controlling Elk-1
transcriptional activity, the sumoylation of Elk-1 is also
proposed to regulate its subcellular localization by promoting
its nuclear retention [117]. This suggests that sumoylation of
Elk-1 may have multiple potentially coupled roles in regulating
Elk-1 activity in cells.
The SUMO E3 ligases responsible for promoting the
sumoylation of Elk-1 have yet to be uncovered, however a
member of the PIAS family of SUMO E3 ligases does bind to
Elk-1 and regulate its activity independently of its E3 ligaseFig. 4. Interplay between the SUMO andMAPK pathways regulates the transcription
of IEGs including c-fos and egr-1 in response to mitogens and stress [112]. At many o
unstimulated cells Elk-1 is sumoylated (S) and recruits an HDAC2 co-repressor com
terminal TAD leading to de-repression by the loss of both sumoylation and HDAC2 a
Elk-1 [118]. In response to stress, p38 MAPK phosphorylates both the transcription
PIASxα by p38 prevents the loss of Elk-1 sumoylation and of the HDAC2 complex f
activity and may serve to dampen down Elk-1-mediated transcription.activity [118]. PIASxα enhances Elk-1 transcriptional activity
in response to growth factors by facilitating the loss of Elk-1
sumoylation and the loss of HDAC2 complex association with
Elk-1 [118] (Fig. 4). In addition, PIASxα upregulates the
activity of the Elk-1 co-activator p300, which contains intrinsic
HAT activity [118]. These activities of PIASxα are dependent
upon Elk-1 and p300 sumoylation and require the SUMO
binding domain located within PIASxα [118]. These data
suggest, somewhat paradoxically, that PIAS proteins are able to
promote both sumoylation and loss of sumoylation depending
on the cellular context. This is supported by other recent studies
that also demonstrate that PIAS proteins are multifunctional
and, in addition to being SUMO E3 ligases, can have E3 ligase-
independent functions including co-activation and co-repres-
sion functions [119].
Interestingly, analogous to the regulation of a ubiquitin E3
ligase by MAPK phosphorylation (as discussed in Section 4.1),
PIASxα can be phosphorylated and regulated by p38 [120]. The
stress-induced activation of the p38 pathway leads to an
increase in Elk-1 activity mediated by p38 phosphorylation of
the C-terminal TAD of Elk-1 [112]. However, only partial
activation of Elk-1 occurs as p38 also phosphorylates at least
two sites in PIASxα which prevents the loss of Elk-1
sumoylation and HDAC2 association, and thereby dampens
down Elk-1 activity [120]. While it is not clear how p38
phosphorylation of PIASxα switches it from a co-activator of
Elk-1 to a co-repressor, this represents a mechanism for graded
transcriptional responses depending on the MAPK pathway
activated. p38 may also regulate other aspects of PIAS function.
It is reported that in response to transforming growth factor-β
(TGFβ), the p38 pathway promotes the expression of PIASxβ
via both increased transcription of the gene and enhancedof IEGs by Elk-1. The ETS-domain transcription factor Elk-1 regulates a number
f these promoters Elk-1 binds as a complex with serum response factor (SRF). In
plex [113,116]. Mitogenic stimuli cause the phosphorylation (P) of the Elk-1 C-
ssociation [113,116]. This is promoted by PIASxαwhich acts as a co-activator of
al activation domain of Elk-1 and also PIASxα [120]. The phosphorylation of
rom the promoter by an unknown mechanism [120]. This results in partial Elk-1
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and transcriptional activity [121].
4.3. MAPK interplay with acetylation in regulating transcription
The acetylation and deacetylation of transcription factors and
chromatin proteins is carried out by histone acetyltransferases
(HATs) and histone deacetylases (HDACs), respectively [122].
While it was originally thought that HAT's act as co-activators
by promoting chromatin relaxation through histone acetylation
and HDACs act as co-repressors by removing acetyl groups
from histones, a more complex picture has now emerged. The
functions of these factors depend on the particular promoter
context and their actions can be coordinated by signaling events
to temporally regulate gene expression. The previously
discussed S. cerevisiae MAPK Hog1, which is an integral part
of transcription factor complexes at osomotic stress-responsive
gene promoters, is essential for the recruitment of the Rpd3–
Sin3 HDAC complex to these promoters [123] (Fig. 2). This
leads to the modification of local chromatin structure by histone
deacetylation and increases the recruitment of RNA polymerase
II and is also likely to allow the recruitment of additional co-
activating factors [123].
Individual transcription factors may coordinate the actions of
multiple HATs and HDACs. In response to ERK activation Elk-
1 dissociates from the HDAC2 co-repressor complex (as
discussed in Section 4.2) and promotes increased HAT activity
of the pre-bound co-activator p300 leading to increased Elk-1
dependent gene transcription [118,124]. Elk-1 mediated gene
expression can be terminated by the recruitment of an mSin3A-
HDAC1 co-repressor complex to an N-terminal repression
domain in the phosphorylated Elk-1 [125]. The coordinated
actions of these HATs and HDACs can serve as a mechanism to
allow rapid switching on and off of Elk-1-mediated transcrip-
tion. A similar scenario occurs during JNK-dependent regula-
tion of AP-1 activity during Drosophila metamorphosis. In this
example JNK phosphorylation of the AP-1 factor dFos results in
increased activity of the associated HAT Chameau (Chm)
towards histone H4 residue Lys14 and promotes target gene
transcription [126]. The de-phosphorylation of dFos leads to the
recruitment of the HDAC dRpd3 which alters the histone
modification pattern to impede gene transcription. [126]. The
balance between the activities of the HAT and HDAC controls
the transient activation of JNK/AP-1 target genes and estab-
lishes a link between MAPK signaling and chromatin
modification in specific developmental processes [126]. It is
important to note that the functional partnership between Chm
and dRpd3 is specific for JNK mediated control of thoracic
closure and apoptosis but does not regulate other JNK-mediated
processes such as dorsal closure, where JNK coordination of the
activities of other HATand HDAC complexes may be important
[126].
MAPKs can directly interact with HATs and HDACs and this
can lead to changes in the activities of both the MAPKs and the
HAT/HDACs. The co-activation properties of p300 and the
closely related HAT CREB-binding protein (CBP) are enhanced
by either ERK phosphorylation or by binding to MSK1 [127–129], while JNK phosphorylation of ATF-2 is reported to
promote its instrinsic HAT activity [130], although this remains
somewhat controversial. In addition, multiple mammalian
MAPKs have been demonstrated to associate with HDACs.
For example ERK binds to HDAC4 and may contribute to its
nuclear localization [131], while HDAC3 complexes associate
with JNK and the p38 isoform p38β and suppress their protein
kinase activities [132,133].
In addition to regulating the activities of HATs and HDACs,
MAPK signaling pathways also target histones in response to a
variety of mitogenic and stress signals. For example, the histone
H2A isoform, H2AX, is phosphorylated by JNK and this is
required for apoptotic DNA fragmentation [134]. The site of
JNK phosphorylation on H2AX, similar to only a handful of
other MAPK substrates, does not conform to the minimal
consensus sequence ([Ser/Thr]-Pro) [134]. This indicates that
additional primary sequences containing Ser or Thr can mimic
the conformation adopted by the [Ser/Thr]-Pro motif and can be
recognised by MAPKs. Other histones, while not direct MAPK
targets, are phosphorylated by downstream protein kinases.
Histone H3 is phosphorylated at Ser10 and Ser28 by MSK1 and
MSK2, downstream kinases of the ERK and p38 pathways
[17,135]. This function of MSKs appears to be evolutionarily
conserved as the Drosophila MSK homolog, JIL-1, also
phosphorylates histone H3 [136]. A second protein kinase
downstream of MAPK pathways, RSK2, has also been
proposed as a histone H3 kinase [137] but there are conflicting
reports as to its importance [138]. Interestingly, Ser28 on
histone H3 can also be phosphorylated by MLTKα, a protein
kinase that is related to the MKKK family of mixed-lineage
kinases (MLKs) [139]. A number of past studies have proposed
that histone H3 phosphorylation promotes its subsequent
acetylation [138]. However, more recent experiments using
cells lacking MSK1 andMSK2, where mitogen-induced histone
H3 phosphorylation does not occur, demonstrate no defects in
acetylation suggesting that these modifications are independent
events rather than being interdependent [135,138]. This does
not exclude an important role for MAPKs in regulating histone
acetylation. Indeed, the JNK pathway is required for the
induction of histone H4 acetylation in response to stress,
although how this occurs is not clear [140]. The mechanisms by
which histone phosphorylation and/or acetylation mediated by
MAPK pathways control the expression of specific genes are
starting to be addressed. It should be borne in mind that only a
relatively small fraction of histone H3 is phosphorylated in cells
and this may induce localized alterations in chromatin structure
that favour the binding of specific transcription factors or
promote the recruitment of chromatin remodelling complexes to
mitogen- and stress-inducible genes [138,141].
5. Concluding remarks
The regulation of transcription by MAPKs is highly complex
with numerous phosphorylation targets ranging from transcrip-
tion factors to co-regulators to components of the GTM and
chromatin proteins. MAPK signaling pathways also interact
with other PTM signaling pathways at gene promoters
1295A.J. Whitmarsh / Biochimica et Biophysica Acta 1773 (2007) 1285–1298increasing the complexity of gene regulation. In addition,
MAPK family members may play an important recruitment role
at particular gene promoters. Despite the recent progress
described in this review it is still a major challenge to fully
understand how developmental and physiological outcomes are
determined by MAPK signaling and how the multiple
individual signaling events are integrated by promoter-bound
transcription factor complexes and chromatin proteins.
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